CATALOGO DEI PRODOTTI DELLA RICERCA

ORSOLINI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.089
NA - Nord America 4.028
AS - Asia 2.996
SA - Sud America 414
AF - Africa 81
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.620
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.929
RU - Federazione Russa 1.760
SG - Singapore 1.183
CN - Cina 936
GB - Regno Unito 649
IT - Italia 455
BR - Brasile 314
DE - Germania 284
VN - Vietnam 252
HK - Hong Kong 219
SE - Svezia 218
FR - Francia 213
IE - Irlanda 190
FI - Finlandia 104
KR - Corea 91
IN - India 86
CA - Canada 58
JP - Giappone 57
UA - Ucraina 38
AR - Argentina 34
NL - Olanda 34
PL - Polonia 34
BD - Bangladesh 28
MX - Messico 27
ZA - Sudafrica 26
AT - Austria 25
ES - Italia 25
BE - Belgio 20
TR - Turchia 20
ID - Indonesia 17
IQ - Iraq 17
NG - Nigeria 15
VE - Venezuela 15
CL - Cile 13
CO - Colombia 12
UZ - Uzbekistan 10
EC - Ecuador 9
PY - Paraguay 9
TG - Togo 9
IR - Iran 8
PH - Filippine 8
PK - Pakistan 8
AZ - Azerbaigian 7
MA - Marocco 7
AU - Australia 6
BJ - Benin 5
CZ - Repubblica Ceca 5
JO - Giordania 5
MY - Malesia 5
RO - Romania 5
EG - Egitto 4
GR - Grecia 4
IL - Israele 4
KE - Kenya 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
DK - Danimarca 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
LT - Lituania 3
NP - Nepal 3
AL - Albania 2
BO - Bolivia 2
CY - Cipro 2
DZ - Algeria 2
HN - Honduras 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
UY - Uruguay 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CD - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CM - Camerun 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
Totale 11.603
Salva come PNG Salva come JPEG
Città #
Singapore 645
Moscow 630
Southend 555
Ashburn 514
Chandler 478
Dallas 404
San Jose 390
Hong Kong 215
Dublin 189
Beijing 160
Jacksonville 136
Redmond 134
Verona 131
The Dalles 115
New York 109
Ann Arbor 94
Los Angeles 89
Ho Chi Minh City 83
Bologna 70
Lawrence 70
Princeton 70
Wilmington 68
Woodbridge 66
Helsinki 59
Hanoi 56
Shenyang 55
Munich 53
Tokyo 53
Jinan 50
Nanjing 45
Redondo Beach 37
Houston 36
São Paulo 36
Denver 35
Tianjin 35
Buffalo 34
Hebei 34
Milan 32
Sindelfingen 30
Montreal 27
Orem 27
Zhengzhou 27
Warsaw 26
Haikou 25
Hangzhou 25
Ningbo 25
Changsha 23
Chicago 23
Guangzhou 22
London 22
Santa Clara 22
Brooklyn 21
Columbus 21
Taiyuan 21
Seattle 20
Brussels 19
Hyderabad 19
Phoenix 18
Vienna 18
Frankfurt am Main 17
Falkenstein 16
Johannesburg 16
Poplar 16
Washington 16
Abuja 15
Nanchang 15
San Francisco 15
Taizhou 15
Turku 15
Atlanta 14
Norwalk 14
Redwood City 14
Jiaxing 13
Manchester 13
Boston 12
Venice 12
Amsterdam 11
Chennai 11
Dong Ket 11
Fuzhou 11
Rio de Janeiro 11
Rome 11
Fairfield 10
Mexico City 10
Tashkent 10
Toronto 10
Da Nang 9
Lomé 9
Mumbai 9
Seoul 9
Jakarta 8
Paris 8
Baku 7
Buenos Aires 7
Charlotte 7
Council Bluffs 7
Haiphong 7
Kent 7
Stockholm 7
Baghdad 6
Totale 7.007
Salva come PNG Salva come JPEG
Nome #
Artrite Reumatoide e Metabolismo Minerale 268
Anti-CCP antibodies and bone 239
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 221
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 218
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 212
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 209
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 202
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 201
Bone involvement and osteoporosis in mastocytosis. 200
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 200
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 194
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 183
A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years’ Experience of the GISM Network 183
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 179
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 176
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 174
Osteoporosis treatment: why ibandronic acid? 172
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 169
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 166
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 165
Bone Disease in Mastocytosis 164
BIOMARKERS LABORATORISTICI RELATIVI AL COINVOLGIMENTO OSSEO NELLE ARTROPATIE INFIAMMATORIE 164
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 162
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 160
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 158
Effects of antiangiogenetic drugs on microcirculation and macrocirculation in patients with advanced-stage renal cancer 157
Relationship between common carotid distensibility/aortic stiffness and cardiac left ventricular morphology and function in a group of patients affected by chronic rheumatic diseases: an observational study 156
Association between environmental air pollution and rheumatoid arthritis flares 156
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 151
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 150
Cardiovascular morbidity and mortality in patients with rheumatic disease: hyperuricemia, a forgotten puzzle piece? 150
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 149
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 149
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 149
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros 146
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 143
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 142
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 141
Rheumatoid arthritis, γδ T cells and bisphosphonates 140
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 139
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 138
Regional differences of vitamin D deficiency in rheumatoid arthritis patients in Italy. 136
High prevalence of occult heart disease in normotensive patients with rheumatoid arthritis 136
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 136
Changes in bone turnover markers and bone modulators during abatacept treatment 134
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 134
Osteoporosis in Rheumatic Diseases 132
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 131
Zoledronic Acid in Osteoporosis Secondary to Mastocytosis. 130
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 129
Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease 129
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 128
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 127
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 124
Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients 121
Traditional cardiovascular risk factors or inflammation: Which factors accelerate atherosclerosis in arthritis patients? 117
Vitamin D serum levels and the risk of digital ulcers in systemic sclerosis: A longitudinal study 117
Incidence and predictors of adverse clinical events in patients with rheumatoid arthritis and asymptomatic left ventricular systolic dysfunction 116
Immunoglobulin G4-Related Disease Responder Index Correlates With the Risk of 1-Year Relapse in Type 1 Autoimmune Pancreatitis 114
Clinical image: ultrasound findings and magnetic resonance imaging comparison in the muscular involvement in polyarteritis nodosa 112
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 112
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 112
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 111
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 110
Ultrasonographic non-radiographic erosions could predict the efficacy of belimumab in articular systemic lupus erythematosus 107
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis 106
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 106
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 100
Incidence and predictors of new onset left ventricular diastolic dysfunction in asymptomatic patients with rheumatoid arthritis without overt cardiac disease 98
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal 97
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 96
Lack of Effect of Teriparatide on Joint Erosions in Rheumatoid Arthritis Is an Expected Result: Comment on the Article by Solomon et al 93
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis? 90
Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life 87
The role of 18FDG-PET imaging in VEXAS syndrome: a multicentric case series and a systematic review of the literature 86
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 85
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis 84
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 84
New insights on the role, pathogenesis, and treatment of osteoporosis and bone erosions in rheumatoid arthritis 81
Subclinical Myocardial Fibrosis in Systemic Lupus Erythematosus as Assessed by Pulse-Cancellation Echocardiography: A Pilot Study 74
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 74
Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement 73
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 72
Prevalence and determinants of vertebral fractures in a SLE cohort 65
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS) 63
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 43
Totale 11.807
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.415
article - articoli 39.970
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 445
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.830
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021116 0 0 0 0 0 0 0 0 0 3 68 45
2021/2022602 56 166 10 40 23 8 19 27 58 10 40 145
2022/20231.332 83 147 105 246 120 311 18 66 167 11 46 12
2023/2024757 32 60 70 90 77 146 30 40 13 26 134 39
2024/20251.710 82 103 77 285 90 50 76 68 265 152 140 322
2025/20265.413 368 286 376 973 1.530 390 535 306 403 246 0 0
Totale 11.807